Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_assertion type Assertion NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_head.
- NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_assertion description "[Bullous pemphigoid (BP) is an acquired autoimmune skin disease, and its target antigens are a 230 kDa plaque protein (BP230) and a 180 kDa transmembrane protein with interrupted collagenous domains (BP180, type XVII collagen), which localize at the hemidesmosome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_provenance.
- NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_assertion evidence source_evidence_literature NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_provenance.
- NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_assertion SIO_000772 10959044 NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_provenance.
- NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_assertion wasDerivedFrom befree-20140225 NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_provenance.
- NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_assertion wasGeneratedBy ECO_0000203 NP455256.RA2mSxmnAbT8wXg737gIwQJt1yEWidYVRQCF4rp8wOhv4130_provenance.